跳至主要内容
临床试验/NCT01597999
NCT01597999Unknown4 期

Accuracy of Magnetic Resonance Imaging (MRI) in Predicting Aggressiveness of Early Breast Cancer According to Molecular Subtypes Identified by ER PR and HER-2 Status

Mahidol University2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2011年2月最近更新:
适应症

试验速览

阶段
4 期
入组人数
60
试验地点
2
主要终点
study the benefits of DCE-MRI using Gadovist in prognostic determination of early invasive breast cancer

研究概览

简要总结

This study examines the additional benefits of magnetic resonance imaging (MRI) with Gadovist in early breast cancer with poor prognostic features.

详细描述

Dedicated Contrast-enhanced Magnetic Resonance Imaging (DCE-MRI)

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Patients with invasive ductal carcinoma
  • Patients undergoing DCE-MRI scan which are assessed according to BI-RADS lexicon
  • Breast cancer patients with pathological diagnosed invasive ductal carcinoma with hormonal receptor (ER, PR and HER-2) response
  • Patients who have signed on informed consent form Patients will undergo MRI imaging and the physicians will practice according to practice guidelines.

排除标准

  • Patients under 18 years old or during pregnancy
  • Patients with MRI's contraindications e.g. patients with cardiac pacemaker or are allergic to MRI contrast agent Patients with unstable clinical abnormality and might get unexpected clinical treatment

结局指标

主要结局

study the benefits of DCE-MRI using Gadovist in prognostic determination of early invasive breast cancer

时间窗: 1 year

The benefits of breast tumor diagnosis from DCE-MRI in early invasive breast cancer with poor prognostic features

次要结局

  • ascertain the accuracy of pre-operative DCE-MRI in terms of detection and characterization of breast cancer, as compared to tissue biopsy.(1 year)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验